Czech Republic

2020 Edition

Czech Clinical Trials: Finding the Niches

The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning that it stands out as one of Central and Eastern Europe’s top destinations for clinical trials. However, a decline in the number of clinical trials in recent years means that Czech stakeholders are looking to find niches in which it can excel to continue its tradition of excellence.

Medtech’s Enduring Importance for Czech Healthcare

Key stakeholders within the Czech medtech industry highlight how medical devices can improve efficiency and quality of care across the country’s healthcare landscape, why greater levels of collaboration are of vital importance to achieving this, and how…

Read the Full Version
Czech Drug Shortages: Both Local & International Solutions Needed

Medicine shortages are a European-wide issue. In 2016, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) formed a task force to investigate availability issues, including medicines that are authorized but not marke…

Orphan Drugs: Building the Regulatory Framework in the Czech Republic

A cross-industry push for better and broader access to innovative treatments is underway in the Czech Republic. Ripe for reform is the country’s orphan drug legislation as no standard pathway for their assessment, pricing and reimbursement currently exists.

A New Era of Access to Innovation in the Czech Republic?

Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or innovative therapies facing significant delays before being able to enter the market.

CEO Profile
Company Spotlight
Jiří Žák
Chairman & CEO of FARMAK

In 1996 Jiří Žák, chairman & current CEO of FARMAK, borrowed half a billion Czech crowns to take over a state-owned producer of vitamins for which he had started working almost 30 years previously.

Company Spotlight
STADA Czech Republic
Finding the Balance

As one of the few pharma companies in the Czech Republic to offer products across the whole healthcare spectrum, including prescription drugs, generics, over-the-counter (OTC) treatments, and food supplements, the 125-year-old German firm STADA has…

Thanks for reading!

The Digital Version of the Healthcare & Life Sciences Review: Czech Republic is available and optimized for desktop browsers.

Visit our website with your computer or download the pdf report

Read the Full Version

2020. Healthcare & Life Sciences Review was produced by Pharmaboardroom.

Copyright: All rights reserved. No part of this publication maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this report, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors. All the images belongs to its respective authors.

Report Director: Georgina Lott
Report Editor: Guillaume Le Maut
Report Coordinator: Delphine Lemercier
Senior Editor: Patrick Burton
Publisher: Mariuca Georgescu
Graphic Designer: Miriam León


Contact us

+44 20 7867 3717

For media inquiries, please contact:


PharmaBoardroom Limited Lynton House, 7-12, Tavistock Square, London, United Kingdom, WC1H 9LT